Canada Legalises Cannabis: Why Aussie Pot Stocks Have Potential

By ,

In the last 24 hours, Canada legalised recreational use of cannabis, or ‘pot,’ in a move that could have a huge impact on markets.

At stake is an estimated market of $200 billion — with more growth on the horizon.

According to Brendan Kennedy, President of Canadian cannabis firm Tilray:

It will be around a $100 billion opportunity over the next five to 10 years.

As of the most recent available statistics, Canada dominates global production and exports, with CA$6.2 billion of the market.

But you have to remember that Canadians smoke a lot of pot, as seen below:

cannabis use around the world on a map


As a result, Reuters reports that ‘Australia will join Uruguay, Israel and the Netherlands in looking to fill the potential shortfall in supply’.

Australian cannabis companies like AusCann Group Holdings Ltd [ASX:AC8] and Cann Group Ltd [ASX:CAN] will look to capitalise by going for quality over quantity, at least initially.

Below, you can see Cann Group’s enticing price performance over the past year:

cann group share price marketindex


David Radford, CEO of Hydroponics Company Ltd [ASX:THC] says that for now:

The Australian cannabis market is akin to the wine industry: you’ll have your premium, Grange hermitage wines, and then you will have goon bags. We will be at the premium end.

If you want to get in on the Aussie pot stock market, we have a free investment guide available here.

Where to find growth in Aussie pot stocks

Another aspect of the budding Australian cannabis market is its potential to focus on intellectual property.

Australia is well known for its research capabilities and there is the option to not just harvest the product, but package it as a pharmaceutical.

GW Pharmaceuticals in the UK for instance, markets products such as an oral solution and a mouth spray.

Other options include treatments for acne and topical pain relief.

But perhaps cannabis’ most exciting prospect for widespread use comes from a little known cannabinoid present in varying amounts, depending on the strain.

A cannabinoid is a class of chemical compounds found in cannabis that acts on receptors in the brain.

There are at least 113 cannabinoids that can be found in cannabis.

The cannabinoid that may be of most interest is called cannabidiol or CBD.

CBD may be the best bet for Aussie pot stocks

CBD is so unique because it doesn’t really get you high.

So what’s the point then?

The point is that CBD is perhaps the most therapeutic of all the cannabinoids.

Its potential uses are vast — it can be used for multiple sclerosis pain, childhood epilepsy, mood disorders and anxiety.

With Australia’s background in research, this may well be the country’s best shot at a cannabis industry for the foreseeable future.

The good news is that in the past two years, the Australian government passed a law that allows for the export of medicinal cannabis products.

Knowing where to start investing can be tricky though.

There are a large range of Aussie pot stocks on the market, and not all of them will be winners.

Luckily we’ve got a free report on how to pick the best pot stocks for you right here.

Happy hunting.


Ryan Clarkson-Ledward,
Money Morning

About Ryan Clarkson-Ledward

Ryan Clarkson-Ledward is an Editor at Money Morning.

Ryan holds degrees in both communication and international business. He helps bring Money Morning readers the latest market updates, both locally and abroad. Ryan tackles all the issues investors need to know about that the mainstream media neglects.

Ryan is also the Editor…

Cann Group Shares Down as It Releases Quarterly Update (ASX:CAN)

Languishing pot stock Cann Group Ltd [ASX:CAN] is being punished by investors today. The CAN share price is down 14.47% at time of writing, falling substantially as management revealed a decent quarterly result and plans for a fresh capital raise.

Cann Group Share Price Rises on Positive News 12.86% (ASX:CAN)

At the time of writing shares of Cann Group Ltd (ASX:CAN) trade at 39.5 cents, up 12.86%. The CAN share price was up on news the medical cannabis company gained approval for new banking debt facilities…

Elixinol Share Price Down: Two Thoughts on its Future

After going to almost $6 a share, it is going for almost a tenth of this price today. We look at what has happened to the Elixinol share price and the company’s restructure.

Why ASX Cannabis Stocks are Down — Should You Invest?

It’s been a tough year for ASX cannabis stocks with many companies shedding value over a 12-month window. Only Althea has emerged from the last year with a gain to show for it. It’s worth taking a look at the ETFMG Alternative Harvest ETF chart to see what’s happening to cannabis stocks globally….

CAN Share Price in the Red: Should You Avoid Large Cannabis Companies?

Indeed, the cannabis craze does appear to be dying down in recent months. But this doesn’t mean the sector no longer has potential. Perhaps it just means bigger isn’t always better when it comes to pot stocks.

Cann Group Share Price Up on Licence (ASX:CAN)

The Cann Group got manufacturing licenses for their facilities in Melbourne today, but their main focus will be on the Canadian market. We look at their valuation…